Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
CNBC • U.S. • 1 hour ago
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
Related News
‘Last chance’: Bessent says Hormuz deal is in sight after Trump's warning on Iran talks
President Donald Trump has warned that the latest round of negotiations with Iran are the "last chance" to bring an end…
CNBC
• 7 minutes ago
What to Watch in Virginia’s First Primary Since Redistricting Battle
Redistricting turmoil started, then ended, the campaigns of several Democratic hopefuls and pushed others into more com…
‘Last chance’: Bessant says Hormuz deal is in sight after Trump's warning on Iran talks
President Donald Trump has warned that the latest round of negotiations with Iran are the "last chance" to bring an end…
CNBC
• 33 minutes ago
Trump warns Iran talks are ‘last chance’ to end war as Qatar confirms diplomatic efforts
President Donald Trump has warned that the latest round of negotiations with Iran are the "last chance" to bring an end…
CNBC
• 1 hour ago
Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion …
CNBC
• 1 hour ago
McDonald's names company veteran Skye Anderson as its U.S. president as growth in its largest market slows
McDonald's new U.S. President Skye Anderson has been with the company for 26 years and succeeds Joe Erlinger in the rol…
CNBC
• 1 hour ago